(Q42707432)

English

The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice

scientific article published on 13 January 2014

Statements

The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice (English)
Takashi Furutani

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit